Artificial Intelligence: An Emerging Intellectual Sword for Battling Carcinomas

Author:

Arfi Sadaf1ORCID,Srivastava Nimisha1,Sharma Nisha2ORCID

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, Amity Institute of Pharmacy, Amity University Uttar Pradesh, Lucknow Campus, Sector 125, Noida, 201313, India

2. Department of Pharmacy, Chhatrapati Shahu Ji Maharaj University Kanpur, 208024, India

Abstract

Abstract: Artificial Intelligence (AI) is a branch of computer science that deals with mathematical algorithms to mimic the abilities and intellectual work performed by the human brain. Nowadays, AI is being effectively utilized in addressing difficult healthcare challenges, including complex biological abnormalities, diagnosis, treatment, and clinical prognosis of various life-threatening diseases, like cancer. Deep neural networking (DNN), a subset of AI, is prominently being applied in clinical research programs on cancer. AI acts as a promising tool in radiotherapy, mammography, imaging, cancer prognosis, cancer genomics and molecular signaling, pathology, drug discovery, chemotherapy, immunotherapy, and clinical decision support system. This article provides an elaborative view concerning the application of AI in cancer, an explorative review that how AI has been used as a trenchant tool in the past, present and future of cancer. This review article provides a new prospective that how the mimic of human intellectual (AI technology) has put forward an unprecedented accuracy in the field of clinical research of cancer.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3